Objectives The Korea Disease Control and Prevention Agency promotes vaccination by regularly providing information on its benefits for reducing the severity of coronavirus disease 2019 (COVID-19). This study aimed to analyze the number of averted severe COVID-19 cases and COVID-19-related deaths by age group and quantify the impact of Republic of Korea’s nationwide vaccination campaign.
Methods We analyzed an integrated database from the beginning of the vaccination campaign on February 26, 2021 to October 15, 2022. We estimated the cumulative number of severe cases and COVID-19-related deaths over time by comparing observed and estimated cases among unvaccinated and vaccinated groups using statistical modeling. We compared daily age-adjusted rates of severe cases and deaths in the unvaccinated group to those in the vaccinated group and calculated the susceptible population and proportion of vaccinated people by age.
Results There were 23,793 severe cases and 25,441 deaths related to COVID-19. We estimated that 119,579 (95% confidence interval [CI], 118,901–120,257) severe COVID-19 cases and 137,636 (95% CI, 136,909–138,363) COVID-19-related deaths would have occurred if vaccination had not been performed. Therefore, 95,786 (95% CI, 94,659–96,913) severe cases and 112,195 (95% CI, 110,870–113,520) deaths were prevented as a result of the vaccination campaign.
Conclusion We found that, if the nationwide COVID-19 vaccination campaign had not been implemented, the number of severe cases and deaths would have been at least 4 times higher. These findings suggest that Republic of Korea’s nationwide vaccination campaign reduced the number of severe cases and COVID-19 deaths.
Citations
Citations to this article as recorded by
Assessing the determinants of influenza and COVID-19 vaccine co-administration decisions in the elderly Seunghyun Lewis Kwon, So-Yeon Kim, Minju Song, Hyung-Min Lee, Seon-Hwa Ban, Mi-Soon Lee, Hyesun Jeong Human Vaccines & Immunotherapeutics.2024;[Epub] CrossRef
코로나바이러스감염증-19 대조 백신 및 연구용 백신 지원 수봉 채, 미미소 이, 은영 조, 준구 박 Public Health Weekly Report.2024; 17(32): 1378. CrossRef
Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023 Ryu Kyung Kim, Young June Choe, Eun Jung Jang, Chungman Chae, Ji Hae Hwang, Kil Hun Lee, Ji Ae Shim, Geun-Yong Kwon, Jae Young Lee, Young-Joon Park, Sang Won Lee, Donghyok Kwon Journal of Korean Medical Science.2023;[Epub] CrossRef
Objectives Healthcare facilities are high-risk sites for infection. This study analyzed the epidemiological characteristics of a coronavirus disease 2019 (COVID-19) outbreak in a tertiary hospital after COVID-19 vaccination had been introduced in Republic of Korea. Vaccine effectiveness (VE) and shared anti-infection strategies are also assessed.
Methods The risk levels for 4,074 contacts were evaluated. The epidemiological characteristics of confirmed cases were evaluated using the chi-square test. The “1 minus relative risk” method was used to determine VE in preventing infection, progression to severe disease, and death. In the largest affected area (the 8th floor), a separate relative risk analysis was conducted. A multivariate logistic regression analysis (with 95% confidence interval [CIs]) was used to identify transmission risk factors with a significance level <10% via the backward elimination method.
Results In total, 181 cases of COVID-19 were confirmed, with an attack rate of 4.4%. Of those cases, 12.7% progressed to severe disease, and 8.3% died. In the cohort isolation area on the 8th floor, where 79.0% of the confirmed cases occurred, the adjusted odds ratio was 6.55 (95% CI, 2.99–14.33) and 2.19 (95% CI, 1.24–3.88) for caregivers and the unvaccinated group, respectively. VE analysis revealed that 85.8% of the cases that progressed to severe disease and 78.6% of the deaths could be prevented by administering a second vaccine.
Conclusion Caregiver training for infection prevention and control is necessary to reduce infection risk. Vaccination is an important intervention to reduce the risk of progression to severe disease and death.
Objectives The coronavirus disease 2019 (COVID-19) pandemic has continued since its first detection in the Republic of Korea on January 20, 2020. This study describes the early countermeasures used to minimize the risk of COVID-19 outbreaks during cohort quarantine and compares the epidemiological characteristics of 2 outbreaks in long-term care facilities (LTCFs) in Gwangju Metropolitan City in summer 2020. Methods: An epidemiological investigation was conducted via direct visits. We investigated epidemiological characteristics, including incidence, morbidity, and mortality rates, for all residents and staff members. Demographic characteristics were analyzed using a statistical program. Additionally, the method of managing infection in LTCFs is described. Results: Residents and caregivers had high incidence rates in LTCF-A and LTCF-B, respectively. LTCF-B had a longer quarantine period than LTCF-A. The attack rate was 20.02% in LTCF-A and 27.9% in LTCF-B. The mortality rate was 2.3% (1/43) in LTCF-B, the only facility in which a COVID-19 death occurred. Conclusion: Extensive management requires contact minimization, which involves testing all contacts to mitigate further transmission in the early stages of LTCF outbreaks. The findings of this study can help inform and prepare public health authorities for COVID-19 outbreaks, particularly for early control in vulnerable facilities.
Citations
Citations to this article as recorded by
Healthcare workers' views on the response to COVID-19 in long-term care hospitals in Korea: a mixed-method study Eun Kyoung Yun, In Seo La, Sunmi Kim, Seongyu Han, Hyungran Lee Frontiers in Public Health.2025;[Epub] CrossRef
Objectives On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir +ritonavir) asa treatment method that could reduce the risk of hospitalization or death for patients withconfirmed coronavirus disease 2019 (COVID-19).Methods: From February 6, 2022 to April 2, 2022, the incidence of COVID-19 and the effectsof treatment with Paxlovid were analyzed in 2,241 patients and workers at 5 long-term carefacilities during the outbreak of the Omicron variant of severe acute respiratory syndromecoronavirus 2 in South Korea.Results: The rate of severe illness or death in the group given Paxlovid was 51% lower thanthat of the non-Paxlovid group (adjusted risk ratio [aRR], 0.49; 95% confidence interval [CI],0.24−0.98). Compared to unvaccinated patients, patients who had completed 3 doses of thevaccine had a 71% reduced rate of severe illness or death (aRR, 0.29; 95% CI, 0.13−0.64) and a65% reduced death rate (aRR, 0.35; 95% CI, 0.15−0.79).Conclusion: Patients given Paxlovid showed a lower rate of severe illness or death and alower fatality rate than those who did not receive Paxlovid. Patients who received 3 dosesof the vaccine had a lower rate of severe illness or death and a lower fatality rate than theunvaccinated group.
Citations
Citations to this article as recorded by
Effectiveness of Nirmatrelvir/Ritonavir for Outpatients in the Era of Omicron, Vaccination, and Previous Infection: A Meta-analysis Mark Ebell, Peter Kurotschka Journal of General Internal Medicine.2026;[Epub] CrossRef
Direct and indirect effects of the COVID-19 pandemic on mortality and critical care utilization in South Korea Mindong Sung, Hye Jin Jang, Soyul Han, Sungho Won, Bora Lee, Young Sam Kim Acute and Critical Care.2026; 41(2): 315. CrossRef
Tracking SARS-CoV-2 RNA in the air: Lessons from a COVID-19 outbreak in an infirmary unit Shuk-Ching Wong, Jonathan Hon-Kwan Chen, Pui-Hing Chau, Wai-On Tam, Germaine Kit-Ming Lam, Lithia Lai-Ha Yuen, Wan-Mui Chan, Allen Wing-Ho Chu, Jonathan Daniel Ip, Hoi-Wah Tsoi, Simon Yung-Chun So, Kelvin Hei-Yeung Chiu, Kwok-Yung Yuen, Kelvin Kai-Wang To American Journal of Infection Control.2025; 53(3): 348. CrossRef
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis Meital Zur, Thalia Peselev, Stav Yanko, Victoria Rotshild, Ilan Matok Antiviral Research.2024; 221: 105768. CrossRef
Clinical Effectiveness of Ritonavir-Boosted Nirmatrelvir—A Literature Review Sydney Paltra, Tim O. F. Conrad Advances in Respiratory Medicine.2024; 92(1): 66. CrossRef
Effectiveness of nirmatrelvir‐ritonavir on severe outcomes of COVID‐19 in the era of vaccination and Omicron: An updated meta‐analysis Sien Ombelet, Diego Castanares‐Zapatero, Fabian Desimpel, Frank Hulstaert, Sabine Stordeur, Dominique Roberfroid Journal of Medical Virology.2024;[Epub] CrossRef
Epidemiological evolution and economic impact of the COVID-19 pandemic in the European Union and worldwide and effects of control strategies on them: An ecological study J.A. Caylà, J.M. Bellmunt, J.M. Jansà, A. Marco, J.P. Millet Medicina de Familia. SEMERGEN.2024; 50(6): 102274. CrossRef
Clinical real-world effectiveness of nirmatrelvir/ritonavir for the treatment of SARS-CoV-2 infection: A meta-analysis Chienhsiu Huang, Sufang Kuo, Lichen Lin Tungs' Medical Journal.2024; 18(Suppl 1): S35. CrossRef
Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID‐19 patients with type 2 diabetes: A target trial emulation study Eric Y. F. Wan, Zoey C. T. Wong, Vincent K. C. Yan, Celine S. L. Chui, Francisco T. T. Lai, Xue Li, Ian C. K. Wong, Esther W. Y. Chan Diabetes, Obesity and Metabolism.2024; 26(10): 4653. CrossRef
COVID‐19 infection in patients with haematological malignancies: A single‐centre survey in the latest Omicron wave in China Xiaolu Zhu, Qian Jiang, Jin Lu, Yuqian Sun, Xiaosu Zhao, Shenmiao Yang, Feifei Tang, Wenjing Yu, Ting Zhao, Xiaohong Liu, Jinsong Jia, Wenbing Duan, Lijuan Hu, Jing Wang, Yang Liu, Nan Peng, Xuelin Dou, Rui Ma, Qiang Fu, Huifang Wang, Kaiyan Liu, Xiaojun British Journal of Haematology.2023; 202(1): 31. CrossRef
The association mental health of adolescents with economic impact during the COVID-19 pandemic: a 2020 Korean nationally representative survey Hanul Park, Kang-Sook Lee BMC Public Health.2023;[Epub] CrossRef
Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis Haokun Tian, Changsen Yang, Tiangang Song, Kechen Zhou, Lequan Wen, Ye Tian, Lirui Tang, Weikai Xu, Xinyuan Zhang Reviews in Medical Virology.2023;[Epub] CrossRef
Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients Min-Kyung Kim, Kyung-Shin Lee, Sin Young Ham, Youn Young Choi, Eunyoung Lee, Seungjae Lee, Bora Lee, Jaehyun Jeon, BumSik Chin, Yeonjae Kim, Gayeon Kim, Hee-Chang Jang, Jae-Phil Choi, Sang-Won Park Journal of Korean Medical Science.2023;[Epub] CrossRef
Effectiveness of Molnupiravir Treatment in Patients with COVID-19 in Korea: A Propensity Score Matched Study Hye Rim Park, Min-Gyu Yoo, Jong Mu Kim, Soon Jong Bae, Hyungmin Lee, Jungyeon Kim Infection & Chemotherapy.2023; 55(4): 490. CrossRef
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19 Stefanie Reis, Maria-Inti Metzendorf, Rebecca Kuehn, Maria Popp, Ildiko Gagyor, Peter Kranke, Patrick Meybohm, Nicole Skoetz, Stephanie Weibel Cochrane Database of Systematic Reviews.2023;[Epub] CrossRef
Objectives Household contacts of confirmed cases of coronavirus disease 2019 (COVID-19) areexposed to a high risk of viral transmission, and secondary incidence is an important indicatorof community transmission. This study analyzed the secondary attack rate and mRNA vaccineeffectiveness against transmission (VET) for index cases (patients treated at home) confirmedto be infected with the Delta and Omicron variants.Methods: The subjects of the study were 4,450 index cases and 10,382 household contacts.Logistic regression analysis was performed to compare the secondary attack rate byvaccination status, and adjusted relative risk and 95% confidence intervals were identified.Results: The secondary attack rate of the Delta variant was 27.3%, while the secondary attackrate of the Omicron variant was 29.8%. For the Delta variant, groups with less than 90 daysand more than 90 days after 2 doses of mRNA vaccination both showed a VET of 37%. For theOmicron variant, a 64% VET was found among those with less than 90 days after 2 doses ofmRNA vaccination.Conclusion: This study provides useful data on the secondary attack rate and VET of mRNAvaccines for household contacts of COVID-19 cases in South Korea.
Citations
Citations to this article as recorded by
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis Dewan Md. Sumsuzzman, Yang Ye, Zhen Wang, Abhishek Pandey, Joanne M. Langley, Alison P. Galvani, Seyed M. Moghadas BMC Infectious Diseases.2025;[Epub] CrossRef
Child Transmission of SARS-CoV-2 Throughout the Pandemic: An Updated Systematic Review and Meta-analysis Eugene Kwon, Gabriel Blank, Samantha Starkey, Cassidy Chapman, Conné Lategan, Hennady Shulha, Vanessa Kitchin, Sarah Silverberg, Laura Sauvé, Manish Sadarangani Pediatric Infectious Disease Journal.2025; 44(7): 696. CrossRef
Household secondary attack rates and risk factors during periods of SARS-CoV-2 Delta and Omicron variant predominance in the Republic of Korea Jin Lee, Mijeong Ko, Seontae Kim, Dosang Lim, Gemma Park, Sang-Eun Lee Osong Public Health and Research Perspectives.2023; 14(4): 263. CrossRef
Shin Young Park, Gawon Choi, Hyeyoung Lee, Na-young Kim, Seon-young Lee, Kyungnam Kim, Soyoung Shin, Eunsu Jang, YoungSin Moon, KwangHwan Oh, JaeRin Choi, Sangeun Lee, Young-Man Kim, Jieun Kim, Seonju Yi, Jin Gwack, Ok Park, Young Joon Park
Osong Public Health Res Perspect 2020;11(4):259-264. Published online August 31, 2020
<p>This study describes the epidemiological characteristics of coronavirus disease 2019 (COVID-19) based on reported cases from long-term care facilities. As of April 20<sup>th</sup>, 2020, 3 long-term care facilities in a metropolitan area of South Korea had reported cases of COVID-19. These facilities’ employees were presumed to be the sources of infection. There were 2 nursing hospitals that did not report any additional cases. One nursing home had a total of 25 cases, with an attack rate of 51.4% (95% CI 35.6–67.0), and a fatality rate of 38.9% (95% CI 20.3–61.4) among residents. The results from this study suggest that early detection and maintenance of infection control minimizes the risk of rapid transmission.</p>
Citations
Citations to this article as recorded by
Factors influencing long-term care facility performance during the COVID-19 pandemic: a scoping review Eric Nguemeleu Tchouaket, Katya Kruglova, Josiane Létourneau, Emilie Bélanger, Stephanie Robins, Maripier Jubinville, Fatima El-Mousawi, Shiyang Shen, Idrissa Beogo, Drissa Sia BMC Health Services Research.2024;[Epub] CrossRef
Impact of the COVID-19 pandemic and corresponding control measures on long-term care facilities: a systematic review and meta-analysis Jun Zhang, Yushan Yu, Mirko Petrovic, Xiaomei Pei, Qing-Bao Tian, Lei Zhang, Wei-Hong Zhang Age and Ageing.2023;[Epub] CrossRef
A scoping review of the impacts of COVID-19 physical distancing measures on vulnerable population groups Lili Li, Araz Taeihagh, Si Ying Tan Nature Communications.2023;[Epub] CrossRef
Analysis of Concentrated COVID-19 Outbreaks in Elderly Facilities in Suita City, Osaka Prefecture, Japan Toshiyuki Shibata, Sawa Okano, Daisuke Onozuka, Etsuko Ohta, Satoshi Kutsuna International Journal of Environmental Research an.2023; 20(20): 6926. CrossRef
Factors relating to intention of use non-face-to-face services among family caregivers of persons with dementia: A cross-sectional study Myonghwa Park, Jinju Kim, Jihye Jung, Seonhwa Kim, Jinhee Lee, Dongyoung Lee Journal of Korean Gerontological Nursing.2023; 25(4): 377. CrossRef
Staffing Levels and COVID-19 Infections and Deaths in Korean Nursing Homes Jiyeon Lee, Juh Hyun Shin, Kyeong Hun Lee, Charlene A. Harrington, Sun Ok Jung Policy, Politics, & Nursing Practice.2022; 23(1): 15. CrossRef
An Experience of the Early Stage of COVID-19 Outbreak in Nursing Homes in Gyeonggi Province, Korea Gawon Choi, Na-young Kim, Seon-young Lee, Hae Deun Noh, Heeyoung Lee Korean Journal of Clinical Geriatrics.2022; 23(1): 27. CrossRef
The implications of the COVID-19 pandemic for long term care facilities Muh-Yong Yen, Jonathan Schwartz, Po-Ren Hsueh Current Opinion in Infectious Diseases.2022; 35(4): 370. CrossRef
Health impact of the first and second wave of COVID-19 and related restrictive measures among nursing home residents: a scoping review Marjolein E. A. Verbiest, Annerieke Stoop, Aukelien Scheffelaar, Meriam M. Janssen, Leonieke C. van Boekel, Katrien G. Luijkx BMC Health Services Research.2022;[Epub] CrossRef
Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysis Mohammad Rashidul Hashan, Nicolas Smoll, Catherine King, Hannah Ockenden-Muldoon, Jacina Walker, Andre Wattiaux, Julieanne Graham, Robert Booy, Gulam Khandaker EClinicalMedicine.2021; 33: 100771. CrossRef
Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence Sally Hall Dykgraaf, Sethunya Matenge, Jane Desborough, Elizabeth Sturgiss, Garang Dut, Leslee Roberts, Alison McMillan, Michael Kidd Journal of the American Medical Directors Associat.2021; 22(10): 1969. CrossRef
Dementia Risk among Coronavirus Disease Survivors: A Nationwide Cohort Study in South Korea Hye-Yoon Park, In-Ae Song, Tak-Kyu Oh Journal of Personalized Medicine.2021; 11(10): 1015. CrossRef
<sec><title>Objectives</title>
<p>In this pandemic situation caused by a novel coronavirus disease in 2019 (COVID-19), an electronic support system that can rapidly and accurately perform epidemic investigations, is needed. It would systematically secure and analyze patients’ data (who have been confirmed to have the infection), location information, and credit card usage.</p></sec>
<sec><title>Methods</title>
<p>The “Infectious Disease Prevention and Control Act” in South Korea, established a legal basis for the securement, handling procedure, and disclosure of information required for epidemic investigations. The Epidemic Investigation Support System (EISS) was developed as an application platform on the Smart City data platform.</p></sec>
<sec><title>Results</title>
<p>The EISS performed the function of inter-institutional communication which reduced the processing period of patients’ data in comparison to other methods. This system automatically marked confirmed cases’ tracking data on a map and hot-spot analysis which lead to the prediction of areas where people may be vulnerable to infection.</p></sec>
<sec><title>Conclusion</title>
<p>The EISS was designed and implemented for use during an epidemic investigation to prevent the spread of an infectious disease, by specifically tracking confirmed cases of infection.</p></sec>
Citations
Citations to this article as recorded by
Missing Occupation, Missing Risk: Insights From COVID-19 Case Investigation Data in Busan, South Korea Jin-Hwan Kim, Daseul Moon, Changhoon Kim Journal of Preventive Medicine and Public Health.2026; 59(2): 204. CrossRef
Surveillance System for Infectious Disease Prevention and Management: Direction of Korea’s Infectious Disease Surveillance System Yumi Jang, Hyungmin Lee, Hyekyung Park Journal of Korean Medical Science.2025;[Epub] CrossRef
The Birth of Digital Epidemiology in South Korea Eun-Sung Kim East Asian Science, Technology and Society: An Int.2024; 18(1): 22. CrossRef
Modern technologies and solutions to enhance surveillance and response systems for emerging zoonotic diseases Li Zhang, Wenqiang Guo, Chenrui Lv Science in One Health.2024; 3: 100061. CrossRef
Epidemiological investigation support application and user evaluation based on infectious disease self-management model in the endemic era Jihwan Park, Mi Jung Rho Health Informatics Journal.2024;[Epub] CrossRef
Health and Environmental Monitoring Services for Smart Healthy Cities : Current Practices and Challenges in Local Government Plans Dong-ah Choi, Yun-jeong Song, Andy Hong Journal of Korea Planning Association.2024; 59(5): 147. CrossRef
Within-Host Evolution of SARS-CoV-2 in a B-Cell Depleted Patient With Successful Treatment Yae Jee Baek, Gemma Park, Jun Yong Choi, Eun Jin Kim, Bryan Inho Kim, Jin Gwack, Ji Ye Jung Journal of Korean Medical Science.2023;[Epub] CrossRef
Contact-tracing of the COVID-19 spreading using digital technologies with artificial intelligence (literary review) Botir T. Daminov, Sherzod P. Ashirbaev, Igor P. Vikhrov HEALTH CARE OF THE RUSSIAN FEDERATION.2023; 67(2): 142. CrossRef
엠폭스(원숭이두창)의 효과적 관리 방안: 역학조사 경험과 국외 정책 검토 태영 김, 언주 박, 종무 김, 민결 심, 신영 이, 은경 김 Public Health Weekly Report.2023; 16(22): 669. CrossRef
Epidemiological analysis of coronavirus disease (COVID-19) patients on ships arriving at Busan port in Korea, 2020 Kee Hun Do, Jinseon Yang, Ok Sook Do, Seok-Ju Yoo, Rajnesh Lal PLOS ONE.2023; 18(7): e0288064. CrossRef
IntelliTrace: Intelligent Contact Tracing Method Based on Transmission Characteristics of Infectious Disease Soorim Yang, Kyoung-Hwan Kim, Hye-Ryeong Jeong, Seokjun Lee, Jaeho Kim Applied System Innovation.2023; 6(6): 112. CrossRef
Detecting mpox infection in the early epidemic: an epidemiologic investigation of the third and fourth cases in Korea Taeyoung Kim, Eonjoo Park, Jun Suk Eun, Eun-young Lee, Ji Won Mun, Yunsang Choi, Shinyoung Lee, Hansol Yeom, Eunkyoung Kim, Jongmu Kim, Jihyun Choi, Jinho Ha, Sookkyung Park Epidemiology and Health.2023; 45: e2023040. CrossRef
A scalable framework for smart COVID surveillance in the workplace using Deep Neural Networks and cloud computing Ajay Singh, Vaibhav Jindal, Rajinder Sandhu, Victor Chang Expert Systems.2022;[Epub] CrossRef
COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains Taewon Han, Heedo Park, Yungje Jeong, Jungmin Lee, Eungyeong Shon, Man-Seong Park, Minki Sung The Journal of Infectious Diseases.2022; 225(9): 1554. CrossRef
Perceived usefulness of COVID-19 tools for contact tracing among contact tracers in Korea Seonyeong Gong, Jong Youn Moon, Jaehun Jung Epidemiology and Health.2022; 44: e2022106. CrossRef
Public health in times of crisis: An overlooked variable in city management theories? Celso Machado, Daielly Melina Nassif Mantovani Ribeiro, Adriana Backx Noronha Viana Sustainable Cities and Society.2021; 66: 102671. CrossRef
Re-estimation of basic reproduction number of COVID-19 based on the epidemic curve by symptom onset date K. Hong, S. J. Yum, J. H. Kim, B. C. Chun Epidemiology and Infection.2021;[Epub] CrossRef
Benefits of Mobile Contact Tracing on COVID-19: Tracing Capacity Perspectives Uichin Lee, Auk Kim Frontiers in Public Health.2021;[Epub] CrossRef
Two-Way Contact Network Modeling for Identifying the Route of COVID-19 Community Transmission Sung Jin Lee, Sang Eun Lee, Ji-On Kim, Gi Bum Kim Informatics.2021; 8(2): 22. CrossRef
State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review Katarzyna Kolasa, Francesca Mazzi, Ewa Leszczuk-Czubkowska, Zsombor Zrubka, Márta Péntek JMIR mHealth and uHealth.2021; 9(6): e23250. CrossRef
Riding the waves of the COVID-19 pandemic in South Korea Joseph Christian Obnial, Maria Beatriz Baron, Hannah Andrea Sagsagat, Erika Ong, Ma. Alexandra Nicola Valenzuela, Don Eliseo Lucero-Prisno The Journal of Primary Health Care.2021; 13(2): 116. CrossRef
Contributions of Smart City Solutions and Technologies to Resilience against the COVID-19 Pandemic: A Literature Review Ayyoob Sharifi, Amir Reza Khavarian-Garmsir, Rama Krishna Reddy Kummitha Sustainability.2021; 13(14): 8018. CrossRef
Harnessing the Power of Smart and Connected Health to Tackle COVID-19: IoT, AI, Robotics, and Blockchain for a Better World Farshad Firouzi, Bahar Farahani, Mahmoud Daneshmand, Kathy Grise, Jaeseung Song, Roberto Saracco, Lucy Lu Wang, Kyle Lo, Plamen Angelov, Eduardo Soares, Po-Shen Loh, Zeynab Talebpour, Reza Moradi, Mohsen Goodarzi, Haleh Ashraf, Mohammad Talebpour, Alireza IEEE Internet of Things Journal.2021; 8(16): 12826. CrossRef
Resolving the tension between full utilization of contact tracing app services and user stress as an effort to control the COVID-19 pandemic Jaehun Joo, Matthew Minsuk Shin Service Business.2020; 14(4): 461. CrossRef
National Disaster Management System: COVID-19 Case in Korea Junic Kim, Kelly Ashihara International Journal of Environmental Research an.2020; 17(18): 6691. CrossRef
Evidence of Long-Distance Droplet Transmission of SARS-CoV-2 by Direct Air Flow in a Restaurant in Korea Keun-Sang Kwon, Jung-Im Park, Young Joon Park, Don-Myung Jung, Ki-Wahn Ryu, Ju-Hyung Lee Journal of Korean Medical Science.2020;[Epub] CrossRef
First
Prev
